Inspecting our data supports that the ATR inhibitors VE-821, VE-822, and AZD6738 were associated with a lower fitness in PTEN-mutant cells of the SKCM, OV, BRCA and DLBC cancer types (Fig. 5c, Additional file 1: Fig. S11d). The gene discussed is PTEN; the disease is cancer.